Allergan Aesthetics
About us
At Allergan Aesthetics, an AbbVie company, we develop, manufacture and market a portfolio with some of the leading aesthetics brands and products. Our aesthetics portfolio includes dermal fillers and body contouring.
With our own research and development function focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
Visit https://www.allerganaesthetics.co.uk/ and follow @AllerganAestheticsUKI to find out more!
Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.
Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
Intended for UK Healthcare Professionals only.
Produced and funded by Allergan Aesthetics, an AbbVie company*.
*Allergan Aesthetics, an AbbVie company is the headline sponsor for the ACE and has part-sponsored this event. This includes provision of a stand, speaker programme and mentors. Allergan Aesthetics has had no influence or involvement over the content or topics covered in other parts of the agenda of the ACE main event.
UK-AGNA-250264 | December 2025
Products
Juvéderm®
Explore Juvéderm®, the world’s leading brand of hyaluronic acid (HA) injectables*. Embrace individuality with Juvéderm®’s versatile portfolio of high-quality hyaluronic acid facial fillers with long-lasting results†. Visit https://www.juvederm.co.uk/ and follow @JuvedermUK on Instagram to find out more! *Based on HCP tracking market research from over 1,700 HCPs from 16 international markets. †Results lasting from 9 months up to 24 months depending on the product used and facial area treated. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com. Intended for UK Healthcare Professionals only. Juvéderm® is intended for those over the age of 18 years. Produced and funded by Allergan Aesthetics, an AbbVie company. UK-AGNA-250264 | December 2025
HArmonyCaᵀᴹ
Combining hyaluronic acid (HA) with calcium hydroxyapatite (CaHA), HArmonyCa is a dual effect injectable that provides an instant lift and sustained collagen stimulation for firm, rejuvenated skin*,†,§. Visit our website https://www.harmonyca.uk/ and follow us @HArmonyCaUK on Instagram to find out more! * Results from a prospective and non-randomised interventional study where HArmonyCa™ was injected in the preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile. † Ultrasound and elastography examinations were performed. When compared to baseline, an increase in density, viscoelasticity, and firmness of the tissue was observed at 60 days and then confirmed at 90 days after treatment. At 180 days after treatment an increase in collagen in the treated areas was confirmed. § Results based on a pre-clinical animal study of HArmonyCa™ with results demonstrated over 12 weeks, which showed that HArmonyCa™ led to an instant lifting-effect following injection. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com. Intended for UK Healthcare Professionals only. HArmonyCaᵀᴹ is intended for those over the age of 18 years. Produced and funded by Allergan Aesthetics, an AbbVie company. UK-AGNA-250264 | December 2025
SKINVIVEᵀᴹ
Meet SKINVIVE™: the only HA (hyaluronic acid) injectable that can deliver up to 9 months of deep† hydration‡ in a single treatment§,‖. SKINVIVE™ gives patients a lasting,¶ hydrated ‡ glow,†† they’ll want to talk about. Visit our website https://www.skinvive.co.uk/content/skinvive-ous/language-masters/en_gb.html and follow us @SkinviveUK on Instagram to find out more! † Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively). ‡ Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31) to correct asymmetry. § Based on a search of published clinical studies of injectable HA treatments in March 2023. A duration of 9 months of skin hydration was established with SKINVIVE™. ‖ A touch up treatment may be required at the clinician’s discretion. †† Lasting up to 9 months as reported by 63% of patients (from a subset of 127 patients at 9 months; n=131 initially enrolled) in a composite satisfaction score, including how radiant their facial skin looked. ¶ Long lasting is up to 9 months following a single treatment. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com. Intended for UK Healthcare Professionals only. SKINVIVEᵀᴹ is intended for those over the age of 18 years. Produced and funded by Allergan Aesthetics, an AbbVie company. UK-AGNA-250264 | December 2025